Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

Anupam Rasayan India Ltd

₹ 1,3551.99%
06 Jan – close price
🔗anupamrasayan.com•BSE: 543275•NSE: ANURAS
Market Cap₹ 15,424 Cr.
Current Price₹ 1,355
High / Low₹ 1,375
Stock P/E120
Book Value₹ 276
Dividend Yield0.06 %
ROCE4.73 %
ROE2.62 %
Face Value₹ 10.0
Sales₹ 1,446 Cr.
OPM26.4 %
Mar Cap₹ 15,424 Cr.

ABOUT

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

KEY POINTS

Business Verticals FY241) Life Science Specialty Chemicals (91%):a. Agrochemicals (65%)-Manufactures agro intermediates and agro active ingredients (insecticides, fungicides, and herbicides) for the agrochemical industry.b. Personal Care (17%) -Manufactures antibacterial and ultraviolet protection intermediates and ingredients for the personal care industry.c. Pharmaceuticals (9%)-The segment focuses on developing intermediates and ‘key starting materials’ for active pharmaceutical ingredients.

Also present in buckets:
Aggressive Growth TriggersExcellent ResultsExcellent ResultsRevenue GuidanceRevenue GuidanceRevenue GuidanceAsset Base ExpansionAsset Base ExpansionCapacity Expansion And ProductsPreferential IssuanceOrder Book PositionOrder Book PositionOrder Book PositionLarge Order ReceiptsJv Partnerships AcquisitionsJv Partnerships AcquisitionsJv Partnerships AcquisitionsRevenue Guidance Vs ActualsRevenue Guidance Vs ActualsCredit Rating UpdatesCredit Rating UpdatesCredit Rating UpdatesRed Flags And Poor Performance

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.Pidilite Inds.1505.0068.24153165.960.66584.608.363554.449.8829.8413817.5923.312244.67579.2316.0316.220.05
2.Gujarat Fluoroch3492.4056.4238364.010.09179.0047.931210.001.859.894864.0026.89680.00179.005.045.510.23
3.Navin Fluo.Intl.5751.0066.3729472.500.21148.37152.24758.4246.2611.682790.9627.91444.09148.378.186.270.33
4.Deepak Nitrite1625.5041.7222170.690.46118.75-38.871901.89-6.4016.287874.8611.16531.41118.714.029.860.23
5.Atul6182.5033.5718202.370.40182.3731.011551.8511.4212.815898.3216.11542.25179.243.087.480.03
6.BASF India3898.0043.8616872.740.51101.05-21.023904.04-8.0918.0214603.554.17384.69101.054.426.070.04
7.Vinati Organics1614.8036.0116739.930.46129.0221.59546.27-1.2720.612258.6529.70464.92129.025.6413.640.00
8.Anupam Rasayan1354.80120.2015424.170.0641.40195.08587.93208.354.731446.3826.36128.3241.404.901.570.38
–Median: 92 Co.292.4828.49878.140.327.343.25134.385.6115.16512.2213.0926.077.352.767.880.11

Quarterly Results

Standalone figures in ₹ crores

Dec 2022Dec 2023Dec 2024Jun 2023Jun 2024Jun 2025Mar 2023Mar 2024Mar 2025Sep 2022Sep 2023Sep 2024Sep 2025
Sales
296215212288164316371308331314317191588
Expenses
206151140210127221279235225219226139479
Operating Profit
8964727837949274106959152109
Other Income
-41-3106518115-5448
Profit before tax
5422135423974425558571155
Tax %
29%29%-47%35%30%24%30%32%31%29%32%-29%24%
Net Profit
3915193513051283841391441
EPS in Rs
3.611.401.743.240.132.704.772.583.464.113.601.283.64

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
2282732882883435025298111,0741,2841,1298961,446
Expenses
1792042082182694083946187709178226311,065
Operating Profit
496980707393134193304367307265381
Other Income
25811619112672261315
Interest
2214212115244569316287107128
Depreciation
51013151823295260667291106
Profit before tax
245054454866719922024217481162
Net Profit
183643353950537015116911773128
EPS in Rs
18.457.278.536.967.7310.0510.607.0015.0415.6910.696.6111.54
Dividend Payout %
0%0%0%0%0%0%0%7%7%16%12%11%–

Compounded Profit Growth

10 Years:7%
5 Years:7%
3 Years:-22%
TTM:117%

Compounded Sales Growth

10 Years:13%
5 Years:11%
3 Years:-6%
TTM:65%

Return on Equity

10 Years:7%
5 Years:6%
3 Years:5%
Last Year:3%

Stock Price CAGR

10 Years:%
5 Years:%
3 Years:25%
1 Year:89%

Balance Sheet

Standalone figures in ₹ crores

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
10505050505050100100107110110114
Reserves
6158971943824325151,4731,6242,2522,6272,6953,031
Borrowings
1171442793184496878464238368221,0671,3231,184
Other Liabilities
2951557097145252300325388547752902
Total Liabilities
2173034816329781,3141,6632,2952,8863,5694,3514,8815,230
Fixed Assets
901452593133796829781,1161,2031,2401,2771,8492,060
Gross Block
114.14178.79304.99373.79457.85782.901,098.931,288.011,433.091,535.121,641.472,304.25–
Accumulated Depreciation
23.7533.3145.8761.2378.77101.10120.68172.04229.95294.89364.54455.61–
CWIP
1216488250183101424311357920634
Investments
02222000148158159159159
Other Assets
1261341572303474495831,1371,4922,0572,3362,6672,977
Total Assets
2173034816329781,3141,6632,2952,8863,5694,3514,8815,230

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
51686917-842951-17124422-65
Cash from Investing Activity
-38-88-168-93-247-261-178-192-412-478-362-286
Cash from Financing Activity
11910073254209102416384376398192
Net Cash Flow
24-100-3-0-919224-19914258-160

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
483628719488899295106176266
Inventory Days
1531582113054112775135288496268491,553
Days Payable
569294156148105225213223202332631
Cash Conversion Cycle
1441011442203582603784077215306921,188
Working Capital Days
1208611379885521168222177162218
ROCE %
–29%22%13%9%9%9%10%11%11%7%5%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters
60.96%60.80%60.77%60.73%61.41%61.26%61.23%61.23%61.19%61.19%61.19%59.07%
FIIs
8.19%8.52%9.79%10.26%9.13%8.07%7.14%7.00%7.46%6.47%4.94%7.63%
DIIs
6.18%4.98%3.74%1.76%2.51%2.56%2.56%2.30%2.32%2.25%2.24%1.37%
Public
24.67%25.68%25.71%27.25%26.96%28.10%29.06%29.47%29.06%30.11%31.65%31.93%

* The classifications might have changed from Sep'2022 onwards.ℹ️

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

Anupam Rasayan Seeks Shareholder Approval for Subsidiary's Credit Facility Guarantees

7th April 2026, 9:25 pm

Anupam Rasayan Board Approves Postal Ballot, E-voting for Subsidiary Guarantees

7th April 2026, 1:40 am

Anupam Rasayan India Ltd. Announces Trading Window Closure

26th March 2026, 11:54 pm

Anupam Rasayan India's Credit Rating Reaffirmed by CRISIL, Removed from 'Watch Negative'

19th March 2026, 4:16 am

Anupam Rasayan India Ltd. to Participate in Investec India Investor Conference on March 11, 2026

7th March 2026, 1:23 am

Published by Other Websites

External media mentions & references

India's Outbound FDI Falls 35% in February: RBI Data

18th March 2026, 7:53 pm

Iran Conflict Sparks Oil Surge; Indian Markets Brace for Gap-Down Open

2nd March 2026, 8:14 am

Anupam Rasayan Expands US Footprint With $150M Jayhawk Fine Chemicals Acquisition

28th February 2026, 3:55 pm

Anupam Rasayan Acquires US Firm Jayhawk for $150M, Eyes Global Growth

27th February 2026, 11:39 pm

Religare Demerger, Copper Tax Hike, Banking Fines: Stocks in Focus

16th February 2026, 7:26 am

News Articles

Editorial & research coverage

Anupam Rasayan: Revenue Surge Masks Margin Erosion Amid Sector Headwinds
Anupam Rasayan: Revenue Surge Masks Margin Erosion Amid Sector Headwinds

14th February 2026, 12:01 pm

India's Chemical Titans: Value in Volatility?
India's Chemical Titans: Value in Volatility?

29th January 2026, 6:42 am

Tanfac Industries Invests ₹495 Cr in New Plant, Eyes ₹500 Cr Equity Fundraise
Tanfac Industries Invests ₹495 Cr in New Plant, Eyes ₹500 Cr Equity Fundraise

9th January 2026, 4:10 pm

Anupam Rasayan's US Acquisition: Jayhawk Deal Ignites Growth and Diversifies Revenue Streams!
Anupam Rasayan's US Acquisition: Jayhawk Deal Ignites Growth and Diversifies Revenue Streams!

16th December 2025, 8:51 am

Promoter Sell-Off Alert: Are India's Top Companies Cashing Out as Market Becomes Expensive?
Promoter Sell-Off Alert: Are India's Top Companies Cashing Out as Market Becomes Expensive?

12th December 2025, 7:55 am

Documents

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

3 Jan - Release of 3,000,000 Anupam Rasayan shares (2.64%) on 31-12-2025; remaining encumbrance 4,250,000 (3.73%).

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Closure of Trading Window
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

24 Dec - Appointment of Milind Madan Talathi as independent director Sep 25, 2025–Sep 24, 2028.

Annual Reports

Financial Year 2025

(from bse)

Financial Year 2024

(from bse)

Financial Year 2023

(from bse)

Financial Year 2022

(from bse)

Financial Year 2021

(from bse)

Credit Ratings

Rating update

18 Dec from crisil

Rating update

13 Oct 2025 from crisil

Rating update

16 Jan 2025 from crisil

Rating update

18 Oct 2024 from fitch

Rating update

10 Jan 2024 from crisil

Rating update

29 Nov 2023 from fitch

Concalls

Dec 2025

TranscriptPPTRecording

Oct 2025

TranscriptPPT

Aug 2025

TranscriptPPT

May 2025

TranscriptPPT

Feb 2025

TranscriptPPT

Nov 2024

TranscriptPPT

Aug 2024

Transcript

Aug 2024

TranscriptPPT

May 2024

TranscriptPPT

Feb 2024

TranscriptPPT

Nov 2023

TranscriptPPT

Aug 2023

TranscriptPPT

May 2023

TranscriptPPT

Jan 2023

TranscriptPPT

Nov 2022

TranscriptPPT

Jul 2022

TranscriptPPT

May 2022

TranscriptPPT

Feb 2022

PPT

Nov 2021

PPT

Nov 2021

PPT

Aug 2021

TranscriptPPT

Jun 2021

PPT

Stock Analysis

Description

Anupam Rasayan India Ltd. is a specialty chemicals manufacturer based in India, involved in producing chemicals sold domestically and exported globally. Its key business segments include Life Science Specialty Chemicals, covering agrochemicals, personal care intermediates, and pharmaceutical intermediates.

Key Growth Triggers

  1. Successful shareholder approval for enhanced borrowing limits and potential disposal of company undertakings to support strategic growth.
  2. Planned acquisition of US-based Monitchem Kansas (Jayhawk Fine Chemicals) for up to $155 million to expand manufacturing and market access.
  3. Strong performance in Q1 and Q2 FY26 with significant YoY revenue and PAT growth, exceeding FY25 total revenue in H1 FY26.
  4. Management guidance for over 50% revenue growth in FY26 and stabilization of EBITDA margins around 25%.
  5. Robust order book of ₹14,646 crore providing revenue visibility.
  6. Expansion into high-growth sectors like semiconductors, electronics, and the EV battery ecosystem.

Order Book

Order Book: December 2025 = ₹14,646 crore

Key Red Flags

  1. Recent credit ratings from CRISIL have been placed on 'Negative Watch', suggesting potential concerns related to the company's financial leverage or future outlook.
  2. While recent quarters show strong growth, FY24-25 annual results indicated a dip in revenue and PAT compared to FY24.
  3. High debtor days (266 days) and inventory days (1,553 days) as per Mar 2025 company data, impacting working capital efficiency.

Key Dates To Watch

  1. Acquisition of Monitchem Kansas expected to complete between January and February 2026.
  2. Q3 FY26 results announcement expected after trading window closure from January 1, 2026.

Corporate Announcements

7th Apr 26
Impact Rating: 6
Anupam Rasayan has initiated a postal ballot to seek shareholder consent for guarantees and security interests linked to Doriath S.à.r.l.'s credit facility, covering scenarios where it may cease to be a wholly-owned subsidiary.
6th Apr 26
Impact Rating: 6
Following its April 6, 2026 Board Meeting, Anupam Rasayan India Ltd. will seek member approval via postal ballot and remote e-voting (April 8 - May 7, 2026) for crucial guarantees and security interests related to subsidiary Doriath S.à.r.l.'s credit facility.
26th Mar 26
Impact Rating: 6
Anupam Rasayan India Ltd. announced a trading window closure from April 1, 2026, per SEBI PIT Regulations. It will reopen 48 hours after the declaration of its audited financial results for the quarter and year ending March 31, 2026.
18th Mar 26
Impact Rating: 8
Anupam Rasayan's credit ratings (A+/A1) reaffirmed by CRISIL and removed from 'Watch Negative'. Successful fundraising for its $150 million US acquisition and improved working capital were key factors. Total rated bank loans: Rs. 1369.82 Crore.
6th Mar 26
Impact Rating: 6
Anupam Rasayan India Ltd. announced participation in the Investec India Promoter & Founder Conference 2026 on March 11, 2026. Management will hold one-on-one and group meetings with investors in Mumbai.